IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IRIS BERANGELL ACOSTA AMEZQUITA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care

NPI
1295482610
CMS profile
11311101
Location
NEWARK, NJ

General Payments · PY2022–2024

$1,915.46

  • Reported across 123 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$765.68

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Primary Care NJ All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $765.68 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $178.57 14
Salix Pharmaceuticals, a division of Bausch Health US, LLC $145.50 9
Bayer HealthCare Pharmaceuticals Inc. $69.51 4
Boehringer Ingelheim Pharmaceuticals, Inc. $66.72 4
Lilly USA, LLC $61.06 4
GlaxoSmithKline, LLC. $55.71 4
PFIZER INC. $49.22 3
Amgen Inc. $46.60 3
Merck Sharp & Dohme Corporation $30.83 2
ABBVIE INC. $30.44 2
Phadia US Inc. $17.17 1
Acerta Pharma LLC $14.35 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $301.42 20
PY2023 $848.36 52
PY2024 $765.68 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.43 01/12/2024 Food and Beverage Undisputed 01/23/2026 1106408959 CMS
ABBVIE INC. $16.01 07/17/2024 Food and Beverage Undisputed 01/23/2026 1106408961 CMS
Amgen Inc. $15.00 02/20/2024 Food and Beverage Undisputed 01/23/2026 1117488842 CMS
Amgen Inc. $15.17 03/22/2024 Food and Beverage Undisputed 01/23/2026 1117488844 CMS
Amgen Inc. $16.43 08/13/2024 Food and Beverage Undisputed 01/23/2026 1117488846 CMS
AstraZeneca Pharmaceuticals LP $14.35 02/19/2024 Food and Beverage Undisputed 01/23/2026 1105549523 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.50 01/20/2024 Food and Beverage Undisputed 01/23/2026 1086321400 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.19 03/05/2024 Food and Beverage Undisputed 01/23/2026 1086356386 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.01 07/11/2024 Food and Beverage Undisputed 01/23/2026 1086352306 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.81 09/16/2024 Food and Beverage Undisputed 01/23/2026 1086281174 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.35 01/22/2024 Food and Beverage Undisputed 01/23/2026 1117952034 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 1117952038 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.37 03/26/2024 Food and Beverage Undisputed 01/23/2026 1117952036 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.00 06/20/2024 Food and Beverage Undisputed 01/23/2026 1117952040 CMS
GlaxoSmithKline, LLC. $15.84 03/19/2024 Food and Beverage Undisputed 01/23/2026 1116492379 CMS
GlaxoSmithKline, LLC. $13.17 04/23/2024 Food and Beverage Undisputed 01/23/2026 1116281833 CMS
GlaxoSmithKline, LLC. $13.20 06/18/2024 Food and Beverage Undisputed 01/23/2026 1116432573 CMS
GlaxoSmithKline, LLC. $13.50 07/09/2024 Food and Beverage Undisputed 01/23/2026 1116019245 CMS
Lilly USA, LLC $15.99 02/15/2024 Food and Beverage Undisputed 01/23/2026 1135669142 CMS
Lilly USA, LLC $16.11 03/28/2024 Food and Beverage Undisputed 01/23/2026 1135683331 CMS
Lilly USA, LLC $15.13 05/04/2024 Food and Beverage Undisputed 01/23/2026 1135702529 CMS
Lilly USA, LLC $13.83 07/04/2024 Food and Beverage Undisputed 01/23/2026 1135641556 CMS
Merck Sharp & Dohme LLC $15.00 04/26/2024 Food and Beverage Undisputed 01/23/2026 1141946099 CMS
Merck Sharp & Dohme LLC $15.83 09/13/2024 Food and Beverage Undisputed 01/23/2026 1141788045 CMS
Novartis Pharmaceuticals Corporation $17.28 01/04/2024 Food and Beverage Undisputed 01/23/2026 1086678381 CMS
Novartis Pharmaceuticals Corporation $16.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086678385 CMS
Novartis Pharmaceuticals Corporation $17.89 04/11/2024 Food and Beverage Undisputed 01/23/2026 1086678387 CMS
Novartis Pharmaceuticals Corporation $17.28 06/06/2024 Food and Beverage Undisputed 01/23/2026 1086678389 CMS
Novartis Pharmaceuticals Corporation $1.32 06/06/2024 Food and Beverage Undisputed 01/23/2026 1086678391 CMS
Novartis Pharmaceuticals Corporation $1.67 06/17/2024 Food and Beverage Undisputed 01/23/2026 1086678393 CMS
Novartis Pharmaceuticals Corporation $17.28 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086678395 CMS
Novartis Pharmaceuticals Corporation $1.43 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086678397 CMS
Novartis Pharmaceuticals Corporation $17.28 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086678401 CMS
Novartis Pharmaceuticals Corporation $1.32 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086678403 CMS
Novartis Pharmaceuticals Corporation $17.28 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086678399 CMS
Novartis Pharmaceuticals Corporation $17.28 09/26/2024 Food and Beverage Undisputed 01/23/2026 1086678405 CMS
Novartis Pharmaceuticals Corporation $17.28 10/24/2024 Food and Beverage Undisputed 01/23/2026 1086678407 CMS
Novartis Pharmaceuticals Corporation $17.28 12/05/2024 Food and Beverage Undisputed 01/23/2026 1086678411 CMS
PFIZER INC. $16.98 02/06/2024 Food and Beverage Undisputed 01/23/2026 1131063076 CMS
PFIZER INC. $16.86 04/16/2024 Food and Beverage Undisputed 01/23/2026 1131373966 CMS
PFIZER INC. $15.38 08/30/2024 Food and Beverage Undisputed 01/23/2026 1131848144 CMS
Phadia US Inc. $17.17 04/03/2024 Food and Beverage Undisputed 01/23/2026 1067579638 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.55 01/03/2024 Food and Beverage Undisputed 01/23/2026 1153445199 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.56 01/31/2024 Food and Beverage Undisputed 01/23/2026 1153633312 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.63 03/05/2024 Food and Beverage Undisputed 01/23/2026 1153730288 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.62 03/20/2024 Food and Beverage Undisputed 01/23/2026 1153490561 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.94 05/13/2024 Food and Beverage Undisputed 01/23/2026 1153678880 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.82 07/03/2024 Food and Beverage Undisputed 01/23/2026 1153678158 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.97 07/17/2024 Food and Beverage Undisputed 01/23/2026 1153704694 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.58 08/21/2024 Food and Beverage Undisputed 01/23/2026 1153464262 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.83 09/26/2024 Food and Beverage Undisputed 01/23/2026 1153658757 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.